Althea presses on with childhood cancer test
This article was originally published in Clinica
Althea Technologies hopes to gain US FDA approval for its gene test for differentiating between four different types of childhood cancer, by the fourth quarter of 2007.
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.